OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION
M De-Limaa, P Kebriaeib, F Lanzac, C Chod, G Popradie, M Kaurf, M Zhangf, F Zhangg, E Vandendriesh, K Asomaningh, S Dormani, M Stelljesj, DI Marksk, A Curyl, W Saberf
a Ohio State University, Blood and Marrow and Cellular Therapy Program, Columbus, United States
b MD Anderson Cancer Center, Houston, United States
c Ospedale di Ravenna, Ravenna, Italy
d John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA
e McGill University Health Centre, Montreal, Canada
f Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, United States
g Pfizer Inc, Shanghai, China
h Pfizer Inc, Cambridge, United States
i Pfizer Inc, Ontario, Canada
j Universitätsklinikum Münster, Münster, Germany
k University Hospitals Bristol NHS Trust, Bristol, United Kingdom
l Pfizer Inc, São Paulo, Brazil
Ver másRead
207
Timeswas read the article
115
Total PDF
92
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 19 | 19 | 38 |
| 2024 April | 13 | 12 | 25 |
| 2024 March | 21 | 12 | 33 |
| 2024 February | 10 | 15 | 25 |
| 2024 January | 4 | 10 | 14 |
| 2023 December | 7 | 16 | 23 |
| 2023 November | 12 | 21 | 33 |
| 2023 October | 6 | 10 | 16 |
